DIPG DMG RESEARCH FUNDING ALLIANCE. (DDRFA)
RESEARCH, TRIAL ACCESS, and DATA USE GRANT
$25,000 - $100,000
DUE September 15, 2025 - MIDNIGHT PT
Our DDRFA grants support (i) basic and/or translational research which intends to provide high impact benefit for better understanding of the brain as it relates to DMG or DIPG, or may improve DIPG or DMG diagnosis, prevention, or treatment; (ii) access to trials or expanded access for DIPG or DMG patients; and (iii) the collection, harmonization, integration or utilization of patient data as it relates to DIPG DMG, which is openly shared. These grants are funded through targeted support of DDRFA members and our philanthropic donors. We look for innovative ideas and gaps in funding which should be filled to move the needle in DIPG DMG discoveries. A new DDRFA funder is also interested in gliomatosis cerebri (GC), a fast growing terminal brain cancer where surgery is usually not an option. As such, please address whether your project will also address or be advantageous in later work to GC prevention, diagnosis or treatment.
1. Applicants may request from $25,000 to $100,000 for a 12-month cycle. Applicants may be funded one-time each year.
2. Applicants may apply for project equipment, personnel salary/wages, personnel tuition support of graduate students directly involved with the grant request, operating supplies, equipment, cell line and lab expenses, imaging time, technology purchases all to be utilized within the United States. Travel necessary to the research, data or trial project by the team may be included. Grant funds will not support general staff or administrative support.
3. Grant award amounts will be determined on an analysis of budget requests and grant funds available. No indirect costs will be available for award. Applicants may budget up to 4% for institutional infrastructure surcharge.
4. Applying students, staff, faculty, or industry investigators must be joined by a researcher who qualifies as a Principal Investigator (PI) by tenure line, medical center line or research faculty appointment.
5. Without further consent of DDRFA, PI's may not be involved in more than two separate proposals per grant cycle, but a PI may be involved in up to two grants awarded during the year.
6. Patients intended to benefit or participate must be treated within the United States.
7. Any IND required must be secured prior to payment of grant funds, and in no event later than three months following the grant award announcement.
8. One year following the grant announcement, successful awardees will provide a written report of research results, detailed fund usage, and a list of publications, articles, webinars, or conference discussions emerging from the research benefited by the grant.
9. Grantee agrees to cite DDRFA as a funding source in peer-reviewed publications from research arising from this award program. Please also acknowledge the DDRFA members funding the award in all non-peer-reviewed articles, in student newspapers, alumni newsletters, institutional magazines, etc. Please forward copies of these news articles to the Collaborative Organization(s) as soon as they are published.
10. The successful grant applicant agrees to include DDRFA's logo or name in such print, web or social media recognition. When appropriate, the grantee will include a graphic provided including all members of DDRFA funding.
11. Awardees must be willing to present the results of their work at a future DDRFA Zoom meeting within six months of completion of the project. A grant awardee may be invited to present at future BrainStorm Summit, DDRFA, or Tough2gether Against DIPG breakfast.
12. Applications are due September 15, 2025 at Midnight PST.